- Current report filing (8-K)
28 Abril 2011 - 6:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 28, 2011
DRUGSTORE.COM, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-26137
|
|
04-3416255
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File No.)
|
|
(IRS Employer
Identification No.)
|
411 108
th
Ave. NE, Suite 1400, Bellevue, Washington 98004
(Address of Principal Executive Offices, Including Zip Code)
(425) 372-3200
(Registrants Telephone Number, Including Area Code)
(Former name
or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
x
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On April 28, 2011, drugstore.com, inc. issued a press release to report preliminary financial results for the first quarter ended April 3, 2011. A copy of the press release is attached hereto as
Exhibit 99.1.
On April 28, 2011,
drugstore.com, inc. issued a press release to report preliminary financial results for the first quarter ended April 3, 2011. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits.
|
|
|
|
|
|
|
|
99.1
|
|
Press release dated April 28, 2011.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
DRUGSTORE.COM, INC.
(Registrant)
|
|
|
By:
|
|
/s/ Yukio Morikubo
|
|
|
Yukio Morikubo
Vice President, Strategy and General Counsel
|
Date: April 28, 2011
Drugstore (NASDAQ:DSCM)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Drugstore (NASDAQ:DSCM)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024